Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Testing | 4 | 2021 | 535 | 0.840 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2022 | 456 | 0.800 |
Why?
|
| Laboratories | 1 | 2021 | 43 | 0.800 |
Why?
|
| Sequence Analysis, DNA | 2 | 2021 | 853 | 0.780 |
Why?
|
| Gene Deletion | 3 | 2021 | 329 | 0.690 |
Why?
|
| Genomics | 4 | 2022 | 720 | 0.640 |
Why?
|
| Uniparental Disomy | 2 | 2020 | 5 | 0.520 |
Why?
|
| Trisomy | 2 | 2017 | 55 | 0.510 |
Why?
|
| Chromosome Aberrations | 3 | 2023 | 387 | 0.480 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2013 | 14 | 0.470 |
Why?
|
| ABO Blood-Group System | 1 | 2013 | 62 | 0.460 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2019 | 2271 | 0.410 |
Why?
|
| Chromosome Disorders | 1 | 2011 | 114 | 0.410 |
Why?
|
| Neural Tube Defects | 2 | 2008 | 43 | 0.400 |
Why?
|
| Gene Duplication | 1 | 2011 | 125 | 0.390 |
Why?
|
| Mutation | 6 | 2022 | 3968 | 0.360 |
Why?
|
| Neoplasms | 2 | 2022 | 2898 | 0.350 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 689 | 0.340 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2007 | 2 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2007 | 48 | 0.300 |
Why?
|
| Linkage Disequilibrium | 2 | 2005 | 473 | 0.300 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2021 | 2357 | 0.280 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2005 | 45 | 0.270 |
Why?
|
| Meningomyelocele | 1 | 2005 | 19 | 0.270 |
Why?
|
| Meningocele | 1 | 2005 | 5 | 0.270 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2005 | 14 | 0.270 |
Why?
|
| Oxidoreductases | 1 | 2005 | 112 | 0.260 |
Why?
|
| Pedigree | 5 | 2019 | 966 | 0.260 |
Why?
|
| Introns | 1 | 2005 | 289 | 0.240 |
Why?
|
| Cerebellar Vermis | 1 | 2023 | 5 | 0.240 |
Why?
|
| Dandy-Walker Syndrome | 1 | 2023 | 20 | 0.230 |
Why?
|
| Microcephaly | 1 | 2023 | 75 | 0.230 |
Why?
|
| Clonal Evolution | 1 | 2023 | 15 | 0.230 |
Why?
|
| Alleles | 2 | 2006 | 1128 | 0.220 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2023 | 86 | 0.220 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2023 | 37 | 0.220 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 136 | 0.210 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 819 | 0.200 |
Why?
|
| INDEL Mutation | 1 | 2021 | 30 | 0.200 |
Why?
|
| Epileptic Syndromes | 1 | 2021 | 4 | 0.200 |
Why?
|
| Microsatellite Instability | 1 | 2021 | 43 | 0.200 |
Why?
|
| Spasms, Infantile | 1 | 2021 | 30 | 0.200 |
Why?
|
| Polycythemia Vera | 1 | 2020 | 23 | 0.190 |
Why?
|
| Biomarkers, Tumor | 4 | 2022 | 1464 | 0.190 |
Why?
|
| Janus Kinase 2 | 1 | 2020 | 57 | 0.190 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 171 | 0.190 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2019 | 4 | 0.180 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 9 | 0.180 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2019 | 12 | 0.180 |
Why?
|
| Granular Cell Tumor | 1 | 2019 | 5 | 0.180 |
Why?
|
| Genetics, Medical | 1 | 2020 | 52 | 0.180 |
Why?
|
| Humans | 22 | 2023 | 86643 | 0.180 |
Why?
|
| Exome | 1 | 2020 | 127 | 0.180 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 110 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2020 | 292 | 0.170 |
Why?
|
| Mosaicism | 2 | 2021 | 67 | 0.160 |
Why?
|
| DiGeorge Syndrome | 1 | 2018 | 14 | 0.160 |
Why?
|
| B-Lymphocytes | 1 | 2023 | 724 | 0.160 |
Why?
|
| Composite Lymphoma | 1 | 2017 | 2 | 0.160 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 294 | 0.160 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2017 | 27 | 0.160 |
Why?
|
| Lymphoma, Follicular | 1 | 2017 | 70 | 0.150 |
Why?
|
| T-Box Domain Proteins | 1 | 2018 | 118 | 0.150 |
Why?
|
| Male | 13 | 2023 | 40965 | 0.150 |
Why?
|
| Lymphoma, B-Cell | 1 | 2017 | 103 | 0.150 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 195 | 0.140 |
Why?
|
| Pregnancy | 3 | 2018 | 2894 | 0.140 |
Why?
|
| DNA Mutational Analysis | 3 | 2008 | 526 | 0.140 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2014 | 33 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 763 | 0.120 |
Why?
|
| Female | 10 | 2023 | 44532 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2013 | 86 | 0.120 |
Why?
|
| Phenotype | 3 | 2023 | 2378 | 0.110 |
Why?
|
| Infant, Newborn | 2 | 2019 | 2379 | 0.110 |
Why?
|
| Ichthyosis, X-Linked | 1 | 2011 | 1 | 0.100 |
Why?
|
| Cytogenetic Analysis | 1 | 2011 | 71 | 0.100 |
Why?
|
| Hair | 1 | 2011 | 56 | 0.100 |
Why?
|
| Malformations of Cortical Development | 1 | 2011 | 39 | 0.100 |
Why?
|
| Syndrome | 1 | 2011 | 446 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2438 | 0.090 |
Why?
|
| Muscle Weakness | 2 | 2008 | 61 | 0.090 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2008 | 9 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2008 | 65 | 0.080 |
Why?
|
| Indians, North American | 1 | 2008 | 48 | 0.080 |
Why?
|
| Twins | 1 | 2008 | 65 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2018 | 623 | 0.080 |
Why?
|
| Mothers | 1 | 2008 | 141 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 2262 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2008 | 247 | 0.070 |
Why?
|
| Haplotypes | 2 | 2008 | 642 | 0.070 |
Why?
|
| Family | 1 | 2008 | 311 | 0.070 |
Why?
|
| Folic Acid | 1 | 2006 | 60 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2007 | 207 | 0.070 |
Why?
|
| Vitamin A | 1 | 2005 | 27 | 0.070 |
Why?
|
| Exons | 2 | 2020 | 450 | 0.070 |
Why?
|
| Organogenesis | 1 | 2005 | 41 | 0.070 |
Why?
|
| Sex Factors | 1 | 2008 | 1054 | 0.070 |
Why?
|
| Gene Frequency | 1 | 2007 | 677 | 0.060 |
Why?
|
| Mice | 3 | 2023 | 11352 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2005 | 249 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 449 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2023 | 51 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2023 | 106 | 0.060 |
Why?
|
| Calpain | 1 | 2023 | 111 | 0.060 |
Why?
|
| Receptor, Notch1 | 1 | 2023 | 85 | 0.060 |
Why?
|
| Genotype | 1 | 2007 | 1851 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2005 | 576 | 0.050 |
Why?
|
| Cerebellum | 1 | 2023 | 247 | 0.050 |
Why?
|
| Sequence Inversion | 1 | 2021 | 3 | 0.050 |
Why?
|
| Genomic Imprinting | 1 | 2020 | 33 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2021 | 3612 | 0.050 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2020 | 24 | 0.050 |
Why?
|
| Facies | 1 | 2019 | 27 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 42 | 0.040 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2019 | 52 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2020 | 270 | 0.040 |
Why?
|
| Animals | 3 | 2023 | 26582 | 0.040 |
Why?
|
| Aged | 3 | 2023 | 18415 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2020 | 201 | 0.040 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2018 | 7 | 0.040 |
Why?
|
| Craniofacial Abnormalities | 1 | 2018 | 36 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 289 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2019 | 265 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2019 | 276 | 0.040 |
Why?
|
| Tetrasomy | 1 | 2017 | 2 | 0.040 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2017 | 9 | 0.040 |
Why?
|
| Antigens, CD20 | 1 | 2017 | 36 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2018 | 62 | 0.040 |
Why?
|
| Risk Factors | 1 | 2008 | 5417 | 0.040 |
Why?
|
| Cardiovascular System | 1 | 2018 | 71 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2022 | 395 | 0.040 |
Why?
|
| Gene Fusion | 1 | 2017 | 38 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2017 | 131 | 0.040 |
Why?
|
| Pneumonectomy | 1 | 2019 | 196 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2020 | 971 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2017 | 348 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 189 | 0.040 |
Why?
|
| Adult | 3 | 2018 | 25648 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2062 | 0.030 |
Why?
|
| Zebrafish | 1 | 2018 | 309 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 351 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 599 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1753 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3679 | 0.030 |
Why?
|
| Middle Aged | 2 | 2023 | 25028 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 5976 | 0.030 |
Why?
|
| Microscopy, Polarization | 1 | 2011 | 10 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 2232 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2014 | 485 | 0.020 |
Why?
|
| Computational Biology | 1 | 2014 | 528 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6509 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1991 | 0.020 |
Why?
|
| Malignant Hyperthermia | 1 | 2008 | 2 | 0.020 |
Why?
|
| North Carolina | 1 | 2008 | 50 | 0.020 |
Why?
|
| Contracture | 1 | 2008 | 18 | 0.020 |
Why?
|
| Consanguinity | 1 | 2008 | 73 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2008 | 85 | 0.020 |
Why?
|
| Homozygote | 1 | 2008 | 200 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2705 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 543 | 0.020 |
Why?
|
| United States | 1 | 2020 | 6672 | 0.020 |
Why?
|
| Child | 1 | 2018 | 6927 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 7993 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1830 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2006 | 128 | 0.020 |
Why?
|
| Adolescent | 1 | 2008 | 8981 | 0.010 |
Why?
|